back to Directory

Sirenas

Sirenas logo

Founded
2011
Patents
7
Publications
5

Technologies

AI Companies (Drug Discovery) Pharmaceutical and Drug Discovery

We bring unparalleled chemical diversity to areas of highest unmet medical need with the team and tools to turn the resulting discoveries into viable, high-impact therapeutics.
Over the last three years, our platform has been validated by pharma partners, helping them increase the chemical diversity of their therapeutic leads, including in cancer and antibiotics. We are now focusing on the discovery and development of novel and differentiated payloads for oncology antibody drug conjugates (ADCs) and have payload programs in various stages of optimization and preclinical development.

Antibody Drug Conjugates


Posts Mentioning This Company

2018 Brings A Surge Of Activity In The “AI For Drug Discovery” Space

  
(Last updated: 15.03.2018) The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate of pharmaceutical research programs has inspired a notable amount of activity over the last several years with a considerable number of initiated research collaborations between AI-driven R&D vendors and top …